img

Global Split Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Split Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
Split Influenza Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Split Influenza Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Split Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi Pasteur
CSL Seqirus
GSK
Seqirus, Inc.
straZeneca
Dalian Yali Peak
Segment by Type
Aldult
Child

Segment by Application


Hospital
Clinic

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Split Influenza Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Split Influenza Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Split Influenza Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Split Influenza Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Split Influenza Vaccine introduction, etc. Split Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Split Influenza Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Split Influenza Vaccine Market Overview
1.1 Split Influenza Vaccine Product Overview
1.2 Split Influenza Vaccine Market Segment by Type
1.2.1 Aldult
1.2.2 Child
1.3 Global Split Influenza Vaccine Market Size by Type
1.3.1 Global Split Influenza Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Split Influenza Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Split Influenza Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Split Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Split Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Split Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Split Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Split Influenza Vaccine Sales Breakdown by Type (2018-2024)
2 Global Split Influenza Vaccine Market Competition by Company
2.1 Global Top Players by Split Influenza Vaccine Sales (2018-2024)
2.2 Global Top Players by Split Influenza Vaccine Revenue (2018-2024)
2.3 Global Top Players by Split Influenza Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Split Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Split Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Split Influenza Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Split Influenza Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Split Influenza Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Split Influenza Vaccine Market
2.8 Key Manufacturers Split Influenza Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Split Influenza Vaccine Status and Outlook by Region
3.1 Global Split Influenza Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Split Influenza Vaccine Historic Market Size by Region
3.2.1 Global Split Influenza Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Split Influenza Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Split Influenza Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Split Influenza Vaccine Forecasted Market Size by Region
3.3.1 Global Split Influenza Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Split Influenza Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Split Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Split Influenza Vaccine by Application
4.1 Split Influenza Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Split Influenza Vaccine Market Size by Application
4.2.1 Global Split Influenza Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Split Influenza Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Split Influenza Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Split Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Split Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Split Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Split Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Split Influenza Vaccine Sales Breakdown by Application (2018-2024)
5 North America Split Influenza Vaccine by Country
5.1 North America Split Influenza Vaccine Historic Market Size by Country
5.1.1 North America Split Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Split Influenza Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Split Influenza Vaccine Sales in Value by Country (2018-2024)
5.2 North America Split Influenza Vaccine Forecasted Market Size by Country
5.2.1 North America Split Influenza Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Split Influenza Vaccine Sales in Value by Country (2024-2029)
6 Europe Split Influenza Vaccine by Country
6.1 Europe Split Influenza Vaccine Historic Market Size by Country
6.1.1 Europe Split Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Split Influenza Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Split Influenza Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Split Influenza Vaccine Forecasted Market Size by Country
6.2.1 Europe Split Influenza Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Split Influenza Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Split Influenza Vaccine by Region
7.1 Asia-Pacific Split Influenza Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Split Influenza Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Split Influenza Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Split Influenza Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Split Influenza Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Split Influenza Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Split Influenza Vaccine Sales in Value by Region (2024-2029)
8 Latin America Split Influenza Vaccine by Country
8.1 Latin America Split Influenza Vaccine Historic Market Size by Country
8.1.1 Latin America Split Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Split Influenza Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Split Influenza Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Split Influenza Vaccine Forecasted Market Size by Country
8.2.1 Latin America Split Influenza Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Split Influenza Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Split Influenza Vaccine by Country
9.1 Middle East and Africa Split Influenza Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Split Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Split Influenza Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Split Influenza Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Split Influenza Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Split Influenza Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Split Influenza Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur Split Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Pasteur Split Influenza Vaccine Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 CSL Seqirus
10.2.1 CSL Seqirus Company Information
10.2.2 CSL Seqirus Introduction and Business Overview
10.2.3 CSL Seqirus Split Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSL Seqirus Split Influenza Vaccine Products Offered
10.2.5 CSL Seqirus Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Split Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Split Influenza Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Seqirus, Inc.
10.4.1 Seqirus, Inc. Company Information
10.4.2 Seqirus, Inc. Introduction and Business Overview
10.4.3 Seqirus, Inc. Split Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Seqirus, Inc. Split Influenza Vaccine Products Offered
10.4.5 Seqirus, Inc. Recent Development
10.5 straZeneca
10.5.1 straZeneca Company Information
10.5.2 straZeneca Introduction and Business Overview
10.5.3 straZeneca Split Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 straZeneca Split Influenza Vaccine Products Offered
10.5.5 straZeneca Recent Development
10.6 Dalian Yali Peak
10.6.1 Dalian Yali Peak Company Information
10.6.2 Dalian Yali Peak Introduction and Business Overview
10.6.3 Dalian Yali Peak Split Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Dalian Yali Peak Split Influenza Vaccine Products Offered
10.6.5 Dalian Yali Peak Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Split Influenza Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Split Influenza Vaccine Industrial Chain Analysis
11.4 Split Influenza Vaccine Market Dynamics
11.4.1 Split Influenza Vaccine Industry Trends
11.4.2 Split Influenza Vaccine Market Drivers
11.4.3 Split Influenza Vaccine Market Challenges
11.4.4 Split Influenza Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Split Influenza Vaccine Distributors
12.3 Split Influenza Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Aldult
Table 2. Major Company of Child
Table 3. Global Split Influenza Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Split Influenza Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Split Influenza Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Split Influenza Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Split Influenza Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Split Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global Split Influenza Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Split Influenza Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Split Influenza Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Split Influenza Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Split Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Split Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Split Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Split Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Split Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Split Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Split Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Split Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Split Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Split Influenza Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Split Influenza Vaccine Sales Share by Company (2018-2024)
Table 26. Global Split Influenza Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Split Influenza Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Split Influenza Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Split Influenza Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Split Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Split Influenza Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Split Influenza Vaccine Market
Table 33. Key Manufacturers Split Influenza Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Split Influenza Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Split Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Split Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Split Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Split Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Split Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global Split Influenza Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Split Influenza Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Split Influenza Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Split Influenza Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Split Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Split Influenza Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Split Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Split Influenza Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Split Influenza Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Split Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global Split Influenza Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Split Influenza Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Split Influenza Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Split Influenza Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Split Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Split Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Split Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Split Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Split Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Split Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Split Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Split Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Split Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Split Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Split Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Split Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Split Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Split Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Split Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America Split Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Split Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Split Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Split Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Split Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Split Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Split Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Split Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe Split Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Split Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Split Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Split Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Split Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Split Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Split Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Split Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Split Influenza Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Split Influenza Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Split Influenza Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Split Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Split Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Split Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Split Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Split Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Split Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Split Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Split Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Split Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Split Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Split Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Split Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Split Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Split Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Split Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Split Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Sanofi Pasteur Company Information
Table 108. Sanofi Pasteur Introduction and Business Overview
Table 109. Sanofi Pasteur Split Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Pasteur Split Influenza Vaccine Product
Table 111. Sanofi Pasteur Recent Development
Table 112. CSL Seqirus Company Information
Table 113. CSL Seqirus Introduction and Business Overview
Table 114. CSL Seqirus Split Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSL Seqirus Split Influenza Vaccine Product
Table 116. CSL Seqirus Recent Development
Table 117. GSK Company Information
Table 118. GSK Introduction and Business Overview
Table 119. GSK Split Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK Split Influenza Vaccine Product
Table 121. GSK Recent Development
Table 122. Seqirus, Inc. Company Information
Table 123. Seqirus, Inc. Introduction and Business Overview
Table 124. Seqirus, Inc. Split Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Seqirus, Inc. Split Influenza Vaccine Product
Table 126. Seqirus, Inc. Recent Development
Table 127. straZeneca Company Information
Table 128. straZeneca Introduction and Business Overview
Table 129. straZeneca Split Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. straZeneca Split Influenza Vaccine Product
Table 131. straZeneca Recent Development
Table 132. Dalian Yali Peak Company Information
Table 133. Dalian Yali Peak Introduction and Business Overview
Table 134. Dalian Yali Peak Split Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Dalian Yali Peak Split Influenza Vaccine Product
Table 136. Dalian Yali Peak Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Split Influenza Vaccine Market Trends
Table 140. Split Influenza Vaccine Market Drivers
Table 141. Split Influenza Vaccine Market Challenges
Table 142. Split Influenza Vaccine Market Restraints
Table 143. Split Influenza Vaccine Distributors List
Table 144. Split Influenza Vaccine Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Split Influenza Vaccine Product Picture
Figure 2. Global Split Influenza Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Split Influenza Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Split Influenza Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Aldult
Figure 6. Global Aldult Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Child
Figure 8. Global Child Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Split Influenza Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Split Influenza Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Split Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Split Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Split Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Split Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Split Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Split Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Split Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Split Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Split Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Split Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Split Influenza Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Split Influenza Vaccine Revenue in 2022
Figure 23. Split Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Split Influenza Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Split Influenza Vaccine Sales Market Share by Application in 2022 & 2029
Figure 30. North America Split Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Split Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Split Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Split Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Split Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Split Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Split Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Split Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Split Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Split Influenza Vaccine Manufacturing Cost Structure
Figure 41. Split Influenza Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries